371
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Effects of treatment with hydroxychloroquine on the modulation of Th17/Treg ratio and pregnancy outcomes in women with recurrent implantation failure: clinical trial

, ORCID Icon, , , , , , , ORCID Icon & ORCID Icon show all
Pages 632-642 | Received 19 Apr 2020, Accepted 03 Oct 2020, Published online: 14 Nov 2020

References

  • Somigliana E, Vigano P, Busnelli A, et al. Repeated implantation failure at the crossroad between statistics, clinics and over-diagnosis. Reprod Biomed Online. 2018;36(1):32–38.
  • Coughlan C, Ledger W, Wang Q, et al. Recurrent implantation failure: definition and management. Reprod Biomed Online. 2014;28(1):14–38.
  • Zenclussen AC, Hämmerling GJ. Cellular regulation of the uterine microenvironment that enables embryo implantation. Front Immunol. 2015;6:321.
  • Saini V, Arora S, Yadav A, et al. Cytokines in recurrent pregnancy loss. Clin Chim Acta. 2011;412(9–10):702–708.
  • Ahmadi M, Abdolmohammadi-Vahid S, Ghaebi M, et al. Regulatory T cells improve pregnancy rate in RIF patients after additional IVIG treatment. Syst Biol Reprod Med. 2017;63(6):350–359.
  • Chen H-H, Chen D-Y, Chen M-J, et al. Decreased ratios of serum Th17/Treg-related cytokines in women with a defect in implantation after in vitro fertilization. Formos J Rheumatol. 2009;23:66–71.
  • Ozkan ZS, Deveci D, Kumbak B, et al. What is the impact of Th1/Th2 ratio, SOCS3, IL17, and IL35 levels in unexplained infertility? J Reprod Immunol. 2014;103:53–58.
  • Heidt S, Segundo DS, San D, et al. The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transplant. 2010;15(4):456–461.
  • Harrity C, Shkrobot L, Walsh D, et al. ART implantation failure and miscarriage in patients with elevated intracellular cytokine ratios: response to immune support therapy. Fertil Res and Pract. 2018;4(1):7.
  • Comins-Boo A, Garcia-Segovia A, Nunez P. Evidence-based update: immunological evaluation of recurrent implantation failure. Reprod Immunol Open Acc. 2016;1(4):1–8.
  • Ruiz-Irastorza G, Egurbide M, Pijoan J, et al. Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus. 2006;15(9):577–583.
  • Kaplan YC, Ozsarfati J, Nickel C, et al. Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;81(5):835–848.
  • Abdolmohammadi-Vahid S, Danaii S, Hamdi K, et al. Novel immunotherapeutic approaches for treatment of infertility. Biomed Pharmacother. 2016;84:1449–1459.
  • Afzali B, Lombardi G, Lechler R, et al. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol. 2007;148(1):32–46.
  • Pongcharoen S, Somran J, Sritippayawan S, et al. Interleukin-17 expression in the human placenta. Placenta. 2007;28(1):59–63.
  • Liang P-Y, Diao L-H, Huang C-Y, et al. The pro-inflammatory and anti-inflammatory cytokine profile in peripheral blood of women with recurrent implantation failure. Reprod Biomed Online. 2015;31(6):823–826.
  • Rajaei S, Zarnani AH, Jeddi-Tehrani M, et al. Cytokine profile in the endometrium of normal fertile and women with repeated implantation failure. Iran J Immunol. 2011;8(4):201–208.
  • Benschop L, Seshadri S, Toulis KA, et al. Immune therapies for women with history of failed implantation undergoing IVF treatment. Cochrane Database Syst Rev. 2012;(1):89–92.
  • Carp H. Immunotherapy for recurrent pregnancy loss. Best Pract Res Clin Obstet Gynaecol. 2019;60:77–86.
  • Silva JC, Mariz HA, Rocha LF, et al. Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients. Clinics (Sao Paulo). 2013;68(6):766–771.
  • Lian F, Zhou J, Wang Y, et al. FRI0338 Hydroxychloroquine may help to improve the in vitro fertilization-embryo transfer outcomes in ana and ds-dna positive patients. BMJ Publishing Group Ltd; 2018;25:249–256.
  • Zhou J, Wang Z, Zhao X, et al. An increase of T reg cells in the peripheral blood is associated with a better in vitro fertilization treatment outcome. Am J Reprod Immunol. 2012;68(2):100–106.
  • Ghasemnejad-Berenji H, Novin MG, Hajshafiha M, et al. Immunomodulatory effects of hydroxychloroquine on Th1/Th2 balance in women with repeated implantation failure. Biomed Pharmacother. 2018;107:1277–1285.
  • Friedman D, Lovig L, Halushka M, et al. No histologic evidence of foetal cardiotoxicity following exposure to maternal hydroxychloroquine. Clin Exp Rheumatol. 2017;35(5):857–859.
  • Mekinian A, Costedoat-Chalumeau N, Masseau A, et al. Obstetrical APS: is there a place for hydroxychloroquine to improve the pregnancy outcome? Autoimmun Rev. 2015;14(1):23–29.
  • Ponticelli C, Moroni G. Hydroxychloroquine in systemic lupus erythematosus (SLE). Expert Opin Drug Saf. 2017;16(3):411–419.
  • Sciascia S, Hunt B, Talavera-Garcia E, et al. The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies. Am J Obstet Gynecol. 2016;214(2):273.e1–273.e8.
  • Clowse ME, Magder L, Witter F, et al. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006;54(11):3640–3647.
  • Pasquier E, de Saint-Martin L, Marhic G, et al. Hydroxychloroquine for prevention of recurrent miscarriage: study protocol for a multicentre randomised placebo-controlled trial BBQ study. BMJ Open. 2019;9(3):e025649.
  • Saifi B, Rezaee SA, Tajik N, et al. Th17 cells and related cytokines in unexplained recurrent spontaneous miscarriage at the implantation window. Reprod Biomed Online. 2014;29(4):481–489.
  • Saito S, Shima T, Nakashima A, et al. What is the role of regulatory T cells in the success of implantation and early pregnancy? J Assist Reprod Genet. 2007;24(9):379–386.
  • Shima T, Sasaki Y, Itoh M, et al. Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. J Reprod Immunol. 2010;85(2):121–129.
  • Robertson SA, Care AS, Moldenhauer LM. Regulatory T cells in embryo implantation and the immune response to pregnancy. J Clin Invest. 2018;128(10):4224–4235.
  • Lee SK, Kim JY, Lee M, et al. Th17 and regulatory T cells in women with recurrent pregnancy loss. Am J Reprod Immunol. 2012;67(4):311–318.
  • Figueiredo AS, Schumacher A. The T helper type 17/regulatory T cell paradigm in pregnancy. Immunology. 2016;148(1):13–21.
  • Tsuda S, Nakashima A, Shima T, et al. New paradigm in the role of regulatory T cells during pregnancy. Front Immunol. 2019;10:573.
  • Kanannejad Z, Jahromi BN, Gharesi-Fard B. T cell subsets profiling in unexplained infertile women with successful and unsuccessful in vitro fertilization outcome: focus on the effect of seminal plasma. Iran J Allergy Asthma Immunol. 2019;18(2):1–10.
  • Wu L, Luo L-H, Zhang Y-X, et al. Alteration of Th17 and Treg cells in patients with unexplained recurrent spontaneous abortion before and after lymphocyte immunization therapy. Reprod Biol Endocrinol. 2014;12(1):74.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.